SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Germany flag Germany · Delayed Price · Currency is EUR
14.86
-0.20 (-1.33%)
Last updated: Apr 28, 2026, 5:35 PM CET
-37.30%
Market Cap 2.24B
Revenue (ttm) 995.03M
Net Income (ttm) 149.95M
Shares Out 150.61M
EPS (ttm) 0.99
PE Ratio 15.02
Forward PE 15.30
Dividend 0.18 (1.20%)
Ex-Dividend Date Feb 4, 2026
Volume 56,997
Average Volume 79,064
Open 15.26
Previous Close 15.06
Day's Range 14.78 - 15.30
52-Week Range 12.62 - 30.25
Beta 0.79
RSI 56.79
Earnings Date May 13, 2026

About ETR:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Sector Healthcare
Founded 1884
Employees 4,829
Stock Exchange Deutsche Börse Xetra
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In fiscal year 2025, ETR:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements

News

There is no news available yet.